([!lemma=clearly] [tag=VBZ])? [!word=in] [lemma=patient] □
([!lemma=clearly] [tag=VBZ])? [!word=in] [lemma=patient] [□]
([!lemma=clearly] [tag=VBZ])? [!word=in] [lemma=patient] □*
These patients may be managed without drug intervention ( provided the patient is not concomitantly using aspirin ) or with cytoreductive therapy.Surgical Care : Patients undergoing surgery are at increased risk for bleeding and thrombosis.Administer cytoreductive therapy to decrease the platelet count to the reference range prior to surgery.Avoid splenectomy because it can markedly increase the platelet count and the risk of both hemorrhagic and thrombotic events.Consultations : A hematologist can help manage patients with ET and monitor the cytoreductive therapy . In other patients with similarly serious infections , a fall in blood pressure or the development of organ failure is slower ( over days ) and cytokine receptors may have already been engaged before circulatory collapse reaches the level of entry criteria into a trial . Patients with Felty syndrome are prone to serious bacterial infections that result in higher rates of morbidity and mortality than for other patients with RA . For example , Partners funds nurse practitioner programs at its acute care hospitals to better manage patients with congestive heart failure . Treatment for patients with thalassemia major includes chronic transfusion therapy , iron chelation , splenectomy , and allogeneic hematopoietic transplantation.Thalassemia minorPatients in the heterozygous state usually do not require treatment.Inform patients that their condition is hereditary and that physicians sometimes mistake the disorder for iron deficiency.Some pregnant patients with the beta thalassemia trait may develop concurrent iron deficiency and severe anemia ; they may require transfusional support if not responsive to iron repletion modalities.Thalassemia majorThe goal of long-term hypertransfusional support is to maintain the patient 's Hb at 9-10 g / dL , thus improving the patient 's sense of well-being while simultaneously suppressing enhanced erythropoiesis . They noted 2 other patients with incidental seizure disorders and EVHCs as corroborating evidence ; however , at this point , no definite evidence supports a new neurocutaneous syndrome involving EVHCs . In this text , the author shares his cancer experience and recovery , as well as the experiences of other patients with cancer . A patient whose blood tests suggest severe hemophilia may only bleed occasionally , whereas another patient with a milder form may bleed more often . Although not currently a reality , future patients with uncomplicated intestinal failure may be considered for intestinal transplantation based on quality-of-life issues .